BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21933042)

  • 1. Detection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array.
    Yujie W; Yu Z; Sixuan Q; Li W; Peng L; Zeng G; Sujiang Z; Jianyong L
    Leuk Lymphoma; 2012 Mar; 53(3):451-5. PubMed ID: 21933042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
    Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
    Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
    Wu B; Zhou S; Song L; Liu X
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
    Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
    Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia.
    Ni H; Nitta M; Komatsu H; Kojima S; Suzuki S; Harada S; Tsuboi K; Banno S; Wakita A; Yazaki M; Ren L; Kato T; Ueda R
    Cancer Lett; 1998 Feb; 124(2):173-80. PubMed ID: 9500207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal residual disease monitoring in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation using interphase fluorescence in situ hybridization and real-time quantitative reverse transcription PCR.
    Zhu HQ; Liu XL; Song LL; Liu QF; Meng FY; Zhou SY
    Chin J Cancer; 2010 Feb; 29(2):194-7. PubMed ID: 20109350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL fusion protein detection in peripheral blood and bone marrow samples of adult precursor B-cell acute lymphoblastic leukemia patients using the flow cytometric immunobead assay.
    Grigoriou EE; Psarra KK; Garofalaki MK; Tziotziou EC; Papasteriades CA
    Clin Chem Lab Med; 2012 Mar; 50(9):1657-63. PubMed ID: 22962228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of tumor-specific antigens in Philadelphia chromosome positive leukemias.
    van Denderen J; ten Hacken P; Berendes P; van Ewijk W
    Leuk Lymphoma; 1993; 11 Suppl 1():29-32. PubMed ID: 7504546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.
    Weerkamp F; Dekking E; Ng YY; van der Velden VH; Wai H; Böttcher S; Brüggemann M; van der Sluijs AJ; Koning A; Boeckx N; Van Poecke N; Lucio P; Mendonça A; Sedek L; Szczepański T; Kalina T; Kovac M; Hoogeveen PG; Flores-Montero J; Orfao A; Macintyre E; Lhermitte L; Chen R; Brouwer-De Cock KA; van der Linden A; Noordijk AL; Comans-Bitter WM; Staal FJ; van Dongen JJ;
    Leukemia; 2009 Jun; 23(6):1106-17. PubMed ID: 19387467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
    Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex RT-PCR for the detection of common BCR-ABL fusion transcripts in paraffin-embedded tissues from patients with chronic myeloid leukemia and acute lymphoblastic leukemia.
    Bock O; Reising D; Kreipe H
    Diagn Mol Pathol; 2003 Sep; 12(3):119-23. PubMed ID: 12960692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An accurate and rapid flow cytometric diagnosis of BCR-ABL positive acute lymphoblastic leukemia.
    Raponi S; De Propris MS; Wai H; Intoppa S; Elia L; Diverio D; Vitale A; Foà R; Guarini A
    Haematologica; 2009 Dec; 94(12):1767-70. PubMed ID: 19608682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of cytogenetic response evaluated by conventional banding analysis and fluorescence in situ hybridization in chronic myeloid leukemia patients during tyrosine kinase inhibitor treatment].
    Wang Z; Li N; Gao L; Feng L; Qin YZ; Dang H; Shi Y; He Q; Jiang Q; Jiang H; Lai YY
    Zhonghua Xue Ye Xue Za Zhi; 2017 Nov; 38(11):962-967. PubMed ID: 29224320
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
    Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.
    Wang WJ; Zheng CF; Liu Z; Tan YH; Chen XH; Zhao BL; Li GX; Xu ZF; Ren FG; Zhang YF; Chang JM; Wang HW
    Eur J Haematol; 2018 Sep; 101(3):291-296. PubMed ID: 29691899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
    Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].
    Qin YZ; Li JL; Zhu HH; Ruan GR; Li LD; Zhang Y; Xu LP; Liu DH; Liu YR; Huang XJ; Chen SS; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):511-4. PubMed ID: 17172121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patients.
    Moumen A; Dehbi H; Kottwitz D; El Amrani M; Bouchoutrouch N; El Hadi H; Quessar A; Benchekroun S; Nadifi S; Sefrioui H
    Genet Mol Res; 2015 Feb; 14(1):1044-55. PubMed ID: 25730044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.